New Study Finds CBD is Beneficial for Psychosis

0
284

The American Journal of Psychiatry recently published a study that shows CBD to be a promising treatment in patients with psychosis. This double-blind study has led researchers to believe that CBD could actually replace antipsychotic medicine that is currently available.

CBD Shows Promise in Reducing Paranoia, Delusions, and Hallucinations

For the study, 88 patients suffering from psychosis were given either 1000mg of CBD or a placebo. After six weeks, individuals who received CBD displayed decreased levels of psychotic symptoms such as paranoia, delusions, and hallucinations.

Research shows that psychosis will affect around one in 13 people by the time the reach the age of 75. It’s described as a “severe mental issue, where there has been some loss of contact with reality.” Psychosis is typically associated with people who have schizophrenia, but there are several mental disorders that can lead to psychosis. Parkinson’s disease and brain tumors can both trigger a psychotic episode, as well as mental disorders such as anxiety, depression, bipolar,  PTSD, and alcohol and drug use.  

The recently conducted study referred that CBD has already showed promise as an antipsychotic in other research that’s been done on both humans and animals. The researchers behind the study wanted to establish “the safety and effectiveness” of CBD on patients with schizophrenia, which is ultimately what they did.

Could CBD Replace Current Antipsychotic Medication?

Professor of Psychiatry & Cognitive Neuroscience at King’s College London, Dr. Phillip McGuire, was the lead author of the study. He’s the one that believes CBD could replace current antipsychotic medications, noting that medication doesn’t always work.

“At present, because CBD is a relatively new drug,” McGuire said, “clinicians might be cautious about using it instead of a well-established treatment like antipsychotic medication. This was one reason why we started by assessing it as an adjunctive or add-on to conventional treatment. However, if trials of CBD as a monotherapy are positive it would be reasonable to consider using it alone, particularly in patients in whom antipsychotic medication hadn’t worked.”

THC-Dominant Strains Can Lead to Paranoia, CBD Can Combat It

While THC has shown to produce anxiety and paranoia in some people that use it, CBD has no psychoactive properties at all. You can’t get high from it, and it does nothing that would compromise a person’s cognitive ability. In fact, CBD can help eliminate the anxiety a person experiences from THC.

The World Health Organization (WHO) even recently recognized the therapeutic value of CBD, noting that it should not be classified by the federal government. CBD is currently a Schedule I Substance, with the US government standing firmly convicted it contains no medical value. This is despite several other countries around the world that have reclassified the substance because of the medical value it contains.

In London for example, where the recent study took place, McGuire notes that “CBD is a major area of research” for his group. They just completed this study on people with psychosis, and are currently studying how CBD can “reduce the adverse effects” some people experience with cannabis.

LEAVE A REPLY